Announcements Trials
Browse Landscape

Status

Completed 5

Sponsor Class

OTHER 5

Study Type

Interventional 40Observational 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Breast Neoplasms 12Rectal Neoplasms 5Urinary Bladder Neoplasms 4Pancreatic Neoplasms 4Neoplasms 4Esophageal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Stomach Neoplasms 3Recurrence 3Ovarian Neoplasms 3Colorectal Neoplasms 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Postoperative Complications 2Pathologic Complete Response 2Head and Neck Neoplasms 2Breast Cancer Patients 2Surgery 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Salivary Gland Neoplasms 1Radiation Injuries 1QOL; Quality of Life;Gastric Cancer; Gastrectomy;Neoadjuvant Chemotherapy 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Peritoneal Neoplasms 1Oropharyngeal Neoplasms 1Neoplastic Cells, Circulating 1Neoplasm, Residual 1Neoplasm Metastasis 1Neoadjuvant Chemotherapy 1

Interventions

Surveys and Questionnaires 12Capecitabine 10Proctectomy 8Surgical Procedures, Operative 7Radiotherapy 7Oxaliplatin 5Neoadjuvant Therapy 5Blood Specimen Collection 5Robotic Surgical Procedures 4Psychiatric Rehabilitation 4Magnetic Resonance Spectroscopy 4Laparoscopy 4Interviews as Topic 4Biopsy 4Amplified Fragment Length Polymorphism Analysis 4Mastectomy, Segmental 3Immunohistochemistry 3Endoscopic Mucosal Resection 3tislelizumab 2Ultrasonography 2Transanal Endoscopic Surgery 2Radiotherapy, Intensity-Modulated 2Polymerase Chain Reaction 2Observation 2Mental Status and Dementia Tests 2Immunotherapy 2Immunologic Techniques 2Genetic Testing 2Gene Expression Profiling 2Drug Therapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Observational × Rectal Neoplasms × Neoadjuvant Therapy × Clear all
NCT05592873 2022-10-25

I-ONARC

Niguarda Hospital

Completed
317 enrolled
Gastrointestinal

Rectal Neoplasms

NCT05496270 2022-08-11

Surgery Alone Versus Neoadjuvant Treatment Followed by Surgery For MRI-defined T3 Mid-low Rectal Cancer

Sun Yat-sen University

Completed
1,509 enrolled
Gastrointestinal

Rectal Neoplasms

NCT05495308 2022-08-10

"Oncologic Results and Risk Factors for Recurrence in Patients With Locally Advanced Rectal Cancer and Pathologic Complete Response After Neoadjuvant Treatment. Results From an Observational Retrospective Multicenter Long-term Follow-up Study".

Hospital San Carlos, Madrid

Completed
4 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03899870 2019-04-02

Factors Predicting Recurrence in Rectal Cancer After Surgery

Université de Sousse

Completed
188 enrolled
Gastrointestinal

Rectal Neoplasms, Recurrence

NCT03151759 2017-05-12

MMP-7

Region Skane

Completed
77 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡